Results 191 to 200 of about 15,580 (252)

Efficacy and safety of dupilumab in moderate-to-severe atopic dermatitis with stage 3-5 chronic kidney disease: a retrospective real-world study. [PDF]

Front Med (Lausanne)
Wei J, Huang Y.
europepmc   +1 more source

Beyond Pigmentation: Dermoscopic Vascular Patterns Reveal Novel Risk and Protective Factors in Melasma

Journal of Cosmetic Dermatology, Volume 25, Issue 11, November 2026.
ABSTRACT Objective To investigate the correlation between the dermoscopic severity of telangiectasia and key pathophysiological features in melasma, and to identify the risk factors associated with vascular pattern severity. Methods In this cross‐sectional study, 137 female melasma patients were classified into four vascular types based on dermoscopic ...
Zhenghui Yang, Jing Wu, Qiuyan Yao, Hua Gu, Ying Tu   +4 more
wiley   +1 more source

Efficacy and Safety of Topical and Systemic Therapies for Atopic Dermatitis in Patients With Skin of Colour: A Systematic Review. [PDF]

Cureus
Waqas M, Sarwar I, Junejo H, Ansari Z, Marshall BA.   +4 more
europepmc   +1 more source

Microbiome‐Based Assessment of Topical Scalp Product‐Associated Microbiome Modulation

Journal of Cosmetic Dermatology, Volume 25, Issue 11, November 2026.
ABSTRACT Background The scalp microbiome plays a crucial role in maintaining scalp health, yet few studies have examined how topical scalp cosmeceuticals affect bacterial and fungal communities. In this study we aim to investigate the impact of a scalp serum on the scalp microbiome and physiology.
Uyen Thy Nguyen, Joseph Skarlupka, Sofia Iglesia, Tatiana Kononov, Alisar Zahr, Elsa Jungman, Haryung Grace Park   +6 more
wiley   +1 more source

Facial Atopic Dermatitis Treated with Chitosan. [PDF]

Life (Basel)
Yi KH, Lee HE, Kim H, Choi W, Kim JH.
europepmc   +1 more source

Baricitinib for Itch-Dominant Atopic Dermatitis: A 52-week Baricitinib Real-World Experience in Korea. [PDF]

Ann Dermatol
Hong N, Gwag HE, Park SY, Heo SJ, Jung HJ, Park MY, Choi YS, Ahn J.   +7 more
europepmc   +1 more source

Immunochemical Markers and Quality of Life in Severe Atopic Dermatitis: A Real-World Analysis. [PDF]

J Korean Med Sci
Choi GS, Oh JH, Kim HK.
europepmc   +1 more source

A Retrospective Cohort Study of Extended Dupilumab Dosing in Atopic Dermatitis: Assessing the Impact on Disease Severity and Understanding Characteristics Linked to Successful Dose Extension. [PDF]

Australas J Dermatol
McClatchy J, Tran V, Ross G.
europepmc   +1 more source

Achieving Targeted Combined Endpoints in Patients With Atopic Dermatitis: A Real-World Study. [PDF]

J Dermatol
Chen YW, Chen YH, Yen TH, Chen YJ, Wu YD, Chen YM, Lin CT, Hsieh TY, Huang WN, Tang KT.   +9 more
europepmc   +1 more source

Development and validation of the Amyloidosis Area and Severity Index for primary cutaneous amyloidosis. [PDF]

JAAD Int
Jiang Z, Wang S, Xiong J, Chen S, Li C, Li Z, Pan Y, Liu C, Yu R, Liu Q, Huang Y, Deng S, Li F, Chen A, He W.   +14 more
europepmc   +1 more source